| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/13/1991 | CA2065442A1 Dopamine releasing protein |
| 04/13/1991 | CA2025314A1 Triglycerides containing saturated fatty acids having 20 to 24 carbon atoms useful in lowering blood cholesterol levels |
| 04/11/1991 | DE4030350A1 New retro:virus protease-inhibiting oligopeptide derivs. - for treatment of retro-viral infection e.g. AIDS |
| 04/11/1991 | DE3932311A1 Purifying equine interferon beta - using anion and cation-exchange columns, useful for antiviral or immuno:modulatory medicament |
| 04/11/1991 | DE3932310A1 New hybrid cell lines producing MABS to equine interferon-beta - for diagnosis of EQIFN-bets esp. enzyme immunoassays or therapy |
| 04/11/1991 | CA2027126A1 Compositions and methods for treating or preventing infections in canine and feline animals |
| 04/11/1991 | CA2025661A1 Method of improving post-ischemic myocardial function using a thromboxane a antagonist in combination with a thrombolytic agent and combination |
| 04/10/1991 | EP0421918A1 Pharmaceutical compositions |
| 04/10/1991 | EP0421876A1 Use of active agents in the preparation of a drug for the treatment of lymphomes or related diseases |
| 04/10/1991 | EP0421682A1 Novel peptides, intermediates therefor, process for preparing the same, and antiallergic agents, vasodilators and immunoregulators |
| 04/10/1991 | EP0421577A2 Solvent extraction process |
| 04/10/1991 | EP0421382A1 Monoclonal antibody to exotoxin A of pseudomonas aeruginosa |
| 04/10/1991 | EP0421367A1 Anticoagulant peptides |
| 04/10/1991 | EP0421366A1 Radiolabeled anticoagulant peptides |
| 04/10/1991 | EP0421309A2 Protein hydrolysates |
| 04/10/1991 | EP0421284A1 Human endothelin-3 cDNA and use thereof |
| 04/10/1991 | EP0421099A2 Methods for modulating promoter responsible for beta amyloid precursor protein expression |
| 04/10/1991 | EP0421074A1 Pharmacologically active peptides and pharmaceutical preparations containing them |
| 04/10/1991 | EP0421059A1 Purified ciliary neurotrophic factor |
| 04/10/1991 | EP0421023A1 Catabolic enzymes for the induction of the tumour necrosis factor (TNF) |
| 04/10/1991 | EP0421022A1 Use of catabolic enzymes to combat a first HIV infection |
| 04/10/1991 | EP0421021A1 Use of catabolic enzymes to activate macrophages and/or NK cells, medicinal composition containing these enzymes for the activation of macrophages and/or NK cells |
| 04/10/1991 | EP0420979A1 Lipid metabolism improving agent and method of its use |
| 04/10/1991 | EP0420964A1 Lyophilized peptide formulations |
| 04/10/1991 | EP0420914A1 Cosmetic and skin treatment compositions. |
| 04/10/1991 | CN1050545A Inhibitor of retroinfection viral protease |
| 04/10/1991 | CN1050503A Stabilized leukocyte-interferons |
| 04/09/1991 | US5006651 Phosphinic acid derivatives |
| 04/09/1991 | US5006642 Purification of von Willebrand Factor by affinity chromatography |
| 04/09/1991 | US5006510 Antinociceptive for burningpain or hyperesthesia |
| 04/09/1991 | US5006509 Use of human growth hormone in treating topical ulcers |
| 04/09/1991 | US5006470 Diagnosis by detecting complex formed between monocloral antibody and melanoma antigen |
| 04/09/1991 | US5006469 Vectors and host cells expressing prepromotilin and motilin-associated peptide (MAP) |
| 04/09/1991 | US5006466 Antibiotics; antitumor, antiulcer agents; analgesics |
| 04/09/1991 | US5006343 Liposomes, alveolar surfactant protein |
| 04/09/1991 | US5006336 Novel coleopteran-active bacillus thuringiensis isolate |
| 04/09/1991 | US5006334 Antigenic modification of polypeptides |
| 04/09/1991 | US5006333 Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
| 04/09/1991 | US5006252 Purified protease nexin |
| 04/09/1991 | US5005655 Partially halogenated ethane solvent removal of oleophylic materials from mineral particles |
| 04/09/1991 | CA1282779C Polysaccharide ron substance, production of the same and use of the same |
| 04/09/1991 | CA1282726C Large scale production of plasminogen activator from normal human colon cells |
| 04/09/1991 | CA1282695C Methods and materials for treatment of rheumatoid arthritis |
| 04/09/1991 | CA1282694C Agent comprising a plasmin inhibitor and a plasminogen activator for the treatment of thromboses |
| 04/07/1991 | WO1991005536A2 Novel oxidized lipoproteins and methods for their preparation |
| 04/07/1991 | WO1991005043A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins |
| 04/07/1991 | WO1991004744A1 Methods and apparatus for treating disease states using oxidized lipoproteins |
| 04/07/1991 | CA2067364A1 Oxidized lipoproteins and methods for their preparation |
| 04/07/1991 | CA2067356A1 Methods for treating diseases using oxidized lipoproteins |
| 04/07/1991 | CA2042605A1 Cytolysis inhibitor proteins (cli), dna sequences coding for said proteins, and plasmids, host organisms, and processes for obtaining said proteins |
| 04/07/1991 | CA2027077A1 Application of active substances for the preparation of a drug for the treatment of lymphomas or related diseases, the drugs thus obtained and a process for the therapeutic treatment of lymphomas |
| 04/05/1991 | CA2026803A1 Monoclonal antibody to exotoxin a of pseudomonas aeruginosa |
| 04/05/1991 | CA2026306A1 Medicament for prevention and remedy of disorders of decrease in the number of blood corpuscles |
| 04/04/1991 | WO1991004493A1 Hiv-related epitopes for diagnosis and immunoprotection |
| 04/04/1991 | WO1991004324A1 Ribozyme compositions and methods for use |
| 04/04/1991 | WO1991004319A1 Therapeutic ribozyme compositions and expression vectors |
| 04/04/1991 | WO1991004277A1 Monoclonal antibodies specific to cytomegalovirus glycoprotein |
| 04/04/1991 | WO1991004247A1 Chimeric amino acids and peptides containing these analogues |
| 04/04/1991 | WO1991004246A1 Method for preparing amino acid derivatives and therapeutical applications of same |
| 04/04/1991 | WO1991004055A1 Treatment of autoimmune disease |
| 04/04/1991 | WO1991004054A1 Treatment of ards |
| 04/04/1991 | WO1991004053A1 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells |
| 04/04/1991 | WO1991004047A1 Synergistic effect of human recombinant interferon-beta on halogenated pyrimidines |
| 04/04/1991 | WO1991004044A1 Method of administering soluble t4 for treatment of human immunodeficiency virus infection |
| 04/04/1991 | WO1991004043A1 Formulation for soluble st4 for treatment of hiv infection |
| 04/04/1991 | WO1991004042A1 Method for inducing vaginal lubrication |
| 04/04/1991 | WO1991004041A1 Process for inducing analgesia, peptides and therapeutic compositions |
| 04/04/1991 | WO1991004039A1 Erection-inducing methods and compositions |
| 04/04/1991 | WO1991004037A1 Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists |
| 04/04/1991 | WO1991004024A1 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| 04/04/1991 | WO1991003948A1 Liquid nutrient composition |
| 04/04/1991 | WO1991002798A3 T-pa mutant gk1l |
| 04/04/1991 | WO1991002719A3 Cck antagonists |
| 04/04/1991 | WO1991001744A3 Uses of interleukin-4 and method for purifying it |
| 04/04/1991 | WO1991000289A3 Targeted liposomes and methods for liposome-protein coupling |
| 04/04/1991 | WO1991000100A3 Toxin uses |
| 04/04/1991 | DE3931839A1 Neue proteine und ihre herstellung New proteins and their production |
| 04/04/1991 | CA2066684A1 Therapeutic ribozyme compositions and expression vectors |
| 04/04/1991 | CA2066647A1 Ribozyme compositions and methods for use |
| 04/04/1991 | CA2026377A1 Radiolabeled anticoagulant peptides |
| 04/03/1991 | EP0420833A1 Method of increasing specific activity of t-PA |
| 04/03/1991 | EP0420649A2 Stabilized aqueous formulations of small peptides |
| 04/03/1991 | EP0420600A2 Use of protease inhibitors as antiexudative, antiphlogistic and antimicrobial agents |
| 04/03/1991 | EP0420502A2 A new plasminogen activator derivative and a method for its manufacture |
| 04/03/1991 | EP0420459A2 Oral pharmaceutical composition for acid sensitive proteinaceous agents |
| 04/03/1991 | EP0420428A2 Mehod of treatment of rheumatoid arthritis using phytic acid |
| 04/03/1991 | EP0420394A1 Monoclonal antibodies against a tumor-associated antigen |
| 04/03/1991 | EP0420224A1 Antihepatopathic composition |
| 04/03/1991 | EP0420222A1 Mutein of acidic FGF, and its production |
| 04/03/1991 | EP0420121A1 Antitumor composition |
| 04/03/1991 | EP0420049A1 Stabilized leucocyte-interferon |
| 04/03/1991 | EP0419878A1 Aprotinin variants and a recombinant method for the microbial preparation of these variants in homogeneously processed form |
| 04/03/1991 | EP0419576A1 Enterically transmitted non-a/non-b hepatitis viral agent |
| 04/03/1991 | EP0419534A1 Wound healing. |
| 04/03/1991 | EP0419501A1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components. |
| 04/03/1991 | CN1050373A Process for preparing optically active 2-aryl-alkanoic acid, in particular 2-aryl propionic |
| 04/03/1991 | CN1050328A Process for preparing dicarbonhydrase mini-capsule having function to protect digestive tract |
| 04/03/1991 | CN1050327A Protein-containing aqueous solutions |
| 04/03/1991 | CN1050321A Thrombolytic composition containing tissue type plasminogen activator or derivative thereof |
| 04/02/1991 | USRE33565 Antibody for passive immunization |